RICOVR’s testing platform leverages the first truly portable nanoparticle detection technology, allowing for fast, non-invasive specimen collection and analytics. With the collaboration of industry experts, the company’s platform is versatile and already expanding into new testing diagnostics including COVID-19, drugs-of-abuse, and critical disease testing.

Medical Devices

Ricovr Healthcare

Himanshu Bhatia

Pratik R. Patel

Gautam Batra

Kavita Gupta

Brett Felmey

Piyush Sadana

Joseph Seimetz

Advisory Team

Leadership Team

Teams at Ricovr Healthcare

Advisory Team

Leadership Team